Patents by Inventor Nicholas John Backes

Nicholas John Backes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260076931
    Abstract: The present invention generally provides methods and compositions for the treatment of Parkinson's disease and depression and/or anxiety. The invention relates to recombinant microorganisms, particularly gut-colonizing probiotics, modified to produce L-DOPA.
    Type: Application
    Filed: November 20, 2025
    Publication date: March 19, 2026
    Inventors: ANUMANTHA G. KANTHASAMY, Ahmed Abdalla, Gregory Phillips, Nicholas John Backes
  • Publication number: 20240016859
    Abstract: The present invention generally provides methods and compositions for the treatment of Parkinson's disease, Alzheimer's disease, depression, anxiety, and memory deficits. The invention relates to recombinant microorganisms, particularly gut-colonizing probiotics, modified to produce L-DOPA as well as microcapsules and lyophilized formulations comprising the same.
    Type: Application
    Filed: August 24, 2023
    Publication date: January 18, 2024
    Inventors: Anumantha G. Kanthasamy, Gregory Phillips, Ahmed Abdalla, Nicholas John Backes, Piyush Padhi
  • Publication number: 20220031771
    Abstract: The present invention generally provides methods and compositions for the treatment of Parkinson's disease, Alzheimer's disease, depression, anxiety, and memory deficits. The invention relates to recombinant microorganisms, particularly gut-colonizing probiotics, modified to produce L-DOPA as well as microcapsules and lyophilized formulations comprising the same.
    Type: Application
    Filed: June 21, 2021
    Publication date: February 3, 2022
    Inventors: Anumantha G. Kanthasamy, Gregory Phillips, Ahmed Abdalla, Nicholas John Backes, Piyush Padhi